Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A. Hatzivasili"'
Autor:
G. Tsirakis, C. A. Pappa, M. Kaparou, V. Katsomitrou, A. Hatzivasili, T. Alegakis, A. Xekalou, E. N. Stathopoulos, M. Alexandrakis
Publikováno v:
European Journal of Histochemistry, Vol 55, Iss 3, Pp e21-e21 (2011)
Multiple myeloma (MM) is a malignant plasma cell disease. Several proinflammatory cytokines produced by malignant plasma cells and bone marrow (BM) stromal cells are involved in the pathogenesis of the disease. We evaluated serum levels of the proinf
Externí odkaz:
https://doaj.org/article/9137033534cd4f958e77f43d1c582d0e
Autor:
Dimitris Xydakis, Ergini Antonaki, Anna Boula, Emilia Stavroulaki, Aristea Hatzivasili, Dimitra Liapi
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 31, Iss 5, Pp 1140-1143 (2020)
Acute kidney injury (AKI) is a well-known complication in patients with chronic lymphocytic leukemia (CLL). It could occur via diverse mechanisms such as leukemic infiltration, extrarenal obstruction, tumor lysis syndrome, glomerular diseases, and me
Externí odkaz:
https://doaj.org/article/07d0821adc19425593e424ed233b6921
Autor:
Emilia Stavroulaki, Anna Boula, Dimitris Xydakis, Aristea Hatzivasili, Dimitra Liapi, Ergini Antonaki
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 31, Iss 5, Pp 1140-1143 (2020)
Acute kidney injury (AKI) is a well-known complication in patients with chronic lymphocytic leukemia (CLL). It could occur via diverse mechanisms such as leukemic infiltration, extrarenal obstruction, tumor lysis syndrome, glomerular diseases, and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fcd69966bd82acd699bd74f334004c8
https://doi.org/10.4103/1319-2442.301184
https://doi.org/10.4103/1319-2442.301184
Autor:
Xydakis, Dimitris, Antonaki, Ergini, Boula, Anna, Stavroulaki, Emilia, Hatzivasili, Aristea, Liapi, Dimitra
Publikováno v:
Saudi Journal of Kidney Diseases & Transplantation; Sep/Oct2020, Vol. 31 Issue 5, p1140-1143, 4p
Autor:
Freda Passam, Michael G. Alexandrakis, Elias Castanas, Aria Hatzivasili, Andreas Foudoulakis, Anna V. Christophoridou, Despina Kyriakou, Kostas Perisinakis
Publikováno v:
American Journal of Hematology. 75:101-106
Interleukin-16 (IL-16) is a chemoattractant of CD4+ lymphocytes, and it has been implicated in the pathogenesis of various inflammatory diseases. There is evidence that it may have a role in multiple myeloma (MM). In the present study, we determined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49908ffa0d0ab88703e8b6ae2b926aa5
https://doi.org/10.1002/ajh.10444
https://doi.org/10.1002/ajh.10444
Autor:
A. Hatzivasili, M. Kaparou, V. Katsomitrou, C. A. Pappa, Efstathios N. Stathopoulos, Athina Xekalou, Michael G. Alexandrakis, George Tsirakis, T. Alegakis
Publikováno v:
European Journal of Histochemistry, Vol 55, Iss 3, Pp e21-e21 (2011)
European Journal of Histochemistry : EJH
European Journal of Histochemistry : EJH
Multiple myeloma (MM) is a malignant plasma cell disease. Several proinflammatory cytokines produced by malignant plasma cells and bone marrow (BM) stromal cells are involved in the pathogenesis of the disease. We evaluated serum levels of the proinf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0b91cae5bb9307a8b97d5f265ccecc
http://www.ejh.it/index.php/ejh/article/view/1840
http://www.ejh.it/index.php/ejh/article/view/1840
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity.
Autor:
Michael G. Alexandrakis, Freda H. Passam, Despina S. Kyriakou, Anna V. Christophoridou, Kostas Perisinakis, Aria Hatzivasili, Andreas Foudoulakis, Elias Castanas
Publikováno v:
American Journal of Hematology; Feb2004, Vol. 75 Issue 2, p101-106, 6p